Drawing for TILBAZ

USPTO serial 77785117

TILBAZ

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
HAN, DAWN L
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with TILBAZ?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christopher M. Hanes

Christopher M. Hanes GlaxoSmithKlineFive Moore DriveLGTM, C.3157.3DResearch Triangle Park, NC 27709

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; vaccinesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 9, 2013MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 9, 2013ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 25, 2013CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 25, 2013COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 15, 2013ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 15, 2013REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 29, 2013EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 28, 2013EX5GSOU EXTENSION 5 GRANTED—
Jan 25, 2013EXT5SOU EXTENSION 5 FILED—
Jan 25, 2013EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 8, 2012EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 7, 2012EX4GSOU EXTENSION 4 GRANTED—
Aug 2, 2012EXT4SOU EXTENSION 4 FILED—
Aug 2, 2012EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 27, 2012EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 26, 2012EX3GSOU EXTENSION 3 GRANTED—
Jan 23, 2012EXT3SOU EXTENSION 3 FILED—
Jan 23, 2012EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 28, 2011EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 27, 2011EX2GSOU EXTENSION 2 GRANTED—
Jul 26, 2011EXT2SOU EXTENSION 2 FILED—
Jul 26, 2011EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 21, 2011EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 20, 2011EX1GSOU EXTENSION 1 GRANTED—
Jan 20, 2011AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Dec 21, 2010EXT1SOU EXTENSION 1 FILED—
Dec 21, 2010EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 10, 2010NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 15, 2010NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 15, 2010PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 14, 2010TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 13, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 13, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 6, 2010DMCCDATA MODIFICATION COMPLETED—
May 6, 2010DMCCDATA MODIFICATION COMPLETED—
Apr 23, 2010RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Mar 18, 2010DMCCDATA MODIFICATION COMPLETED—
Mar 18, 2010ALIEASSIGNED TO LIE—
Mar 17, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 17, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 17, 2010ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Oct 26, 2009TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 21, 2009GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Oct 21, 2009GNSLLETTER OF SUSPENSION E-MAILED—
Oct 21, 2009CNSLSUSPENSION LETTER WRITTEN—
Oct 21, 2009XAECEXAMINER'S AMENDMENT ENTERED—
Oct 21, 2009GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 21, 2009GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 21, 2009CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 12, 2009GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 12, 2009GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 12, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 7, 2009DOCKASSIGNED TO EXAMINER—
Jul 23, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 23, 2009NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance